๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Salivary Gland Carcinoma

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas NCT04620187Phase 213 sites๐Ÿ“ Atlanta๐Ÿ“ Chicago๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy, Standard of Care Chemotherapy An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation NCT04214366Phase 21 site๐Ÿ“ Heidelberg Heidelberg University ยท Tests: Carbon ion irradiation, Bimodal irradiation Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer NCT07667400Phase 1, Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: SX-682, DTX Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma NCT06348264Phase 22 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University First Hospital ยท Tests: Rezvilutamide, Leuprolide Acetate Immune Biomarker Study for Salivary Gland Carcinoma NCT06047236n/a2 sites๐Ÿ“ Erlangen๐Ÿ“ Erlangen University of Erlangen-Nรผrnberg Medical School ยท Tests: Sampling Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants NCT00898638n/a4 sites๐Ÿ“ Nashville๐Ÿ“ Nashville๐Ÿ“ Nashville Vanderbilt University Medical Center ยท Tests: biologic sample preservation procedure, medical chart review PDO Based Drug Sensitive Test in R/M SGC NCT06686979n/a2 sites๐Ÿ“ Shanghai๐Ÿ“ Shanghai Huashan Hospital ยท Tests: No Intervention: Observational Cohort Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers NCT00900419n/a1 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: immunohistochemistry staining method, laboratory biomarker analysis, sputum cytology, biopsy Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" NCT01365169NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Exercise Intervention, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing NCT06145308Phase 22 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Peking Union Medical College ยท Tests: Cohort 1 (HER2-positive, RC48-ADC), Cohort 2 (NTRK-fusion or NTRK-mutant), Cohort 3 (AR-positive, leuprolide + bicalutaโ€ฆ Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites๐Ÿ“ Greenwood Village๐Ÿ“ Manchester๐Ÿ“ Daytona Beach University of Nebraska A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma NCT07507578n/a1 site๐Ÿ“ Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano ยท Tests: Standard of Care (Investigator Choice) Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) NCT06923826Phase 21 site๐Ÿ“ Singapore National University Hospital, Singapore ยท Tests: Sacituzumab govitecan First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor NCT07755397Phase 16 sites๐Ÿ“ Surat๐Ÿ“ Bangalore๐Ÿ“ Mumbai Jubilant Therapeutics India Limited ยท Tests: JBI-778 Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study NCT05946577n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer NCT00588185NA7 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers NCT05483374n/a10 sites๐Ÿ“ Brno๐Ÿ“ Essen๐Ÿ“ Genova Fondazione IRCCS Istituto Nazionale dei Tumori, Milano ยท Tests: observation A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers NCT06805617Phase 22 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Ivonescimab The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study NCT07464366Phase 21 site๐Ÿ“ Shanghai Ji Dongmei ยท Tests: MRG 003, Pucotenlimab Oropharynx (OPX) Biomarker Trial NCT06356272n/a1 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Non-Interventional Study Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma NCT07686575n/a2 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Zhujiang Hospital ยท Tests: Ivonescimab๏ผˆAK112๏ผŒa PD-1/VEGF bispecific antibody๏ผ‰ A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors NCT05941507Phase 1, Phase 28 sites๐Ÿ“ Los Angeles๐Ÿ“ Boston๐Ÿ“ Ann Arbor LigaChem Biosciences, Inc. ยท Tests: LCB84, Anti-PD-1 monoclonal antibody Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors NCT03740256Phase 11 site๐Ÿ“ Houston Baylor College of Medicine ยท Tests: CAdVEC d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC NCT04392622Phase 11 site๐Ÿ“ Stanford Stanford University ยท Tests: D-Limonene Gelcaps, Intensity modulated radiotherapy (IMRT), Cisplatin, Xerostomia questionnaire Prospective Registry Study on the Implementation of Simultaneous Postoperative Radiochemotherapy for Salivary Gland Carcinomas of the Head and Neck Region NCT06464198n/a1 site๐Ÿ“ Erlangen University of Erlangen-Nรผrnberg Medical School ยท Tests: simultaneous postoperative radiochemotherapy DESTINY-PANTUMOUR04 NCT07124000n/a18 sites๐Ÿ“ Birmingham๐Ÿ“ Bullhead City๐Ÿ“ Casa Grande AstraZeneca ยท Tests: Trastuzumab deruxtecan A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors NCT06695845Phase 228 sites๐Ÿ“ Prescott๐Ÿ“ Littleton๐Ÿ“ Fort Myers Jazz Pharmaceuticals ยท Tests: Zanidatamab VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites๐Ÿ“ Santa Rosa๐Ÿ“ Hartford๐Ÿ“ Washington D.C. VM Oncology, LLC ยท Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers NCT05553782EARLY Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Implantable Microdevice (IMD)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy